The search terms included post-stroke depression, monoamine neurotransmitters, HPA axis, neurotoxicity, neural circuits, neuroplasticity, neuroimmunity, gut-brain axis, natural products, anti-post-stroke antidepressants, and toxicity. The inclusion criteria were as follows: a) original publications in English, b) experimental research articles related to the pathological mechanisms of PSD, c) studies investigating the mechanisms of NPs treatment for PSD using PSD models, and d) studies related to the toxicology of NPs
Studies report protective outcomes in liver and pancreatic injury, periodontal damage, soft tissue trauma, and even neurological impairments, including conditions involving altered serotonergic and dopaminergic signaling
As part of surgical meshes or fibrin glues, they provide a delivery route and the peptides act where they are needed most
Research Context In experimental settings, FOXO4-DRI is used to explore: Cellular senescence and ageing-associated signalling cascades FOXO4p53 interaction dynamics in senescent cell survival Experimental senescence-focused research models Stress and cytotoxic response pathways involving senescence markers Comparative in-vitro studies alongside FOXO4 and related research compounds Its structured D-retro-inverso design makes FOXO4-DRI suitable for controlled laboratory research where precise modulation of FOXO4-linked pathways is required
